Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Iron-responsive element (IRE) is a highly conserved RNA stem-loop structure located in the 5'-untranslated region (UTR) of mRNAs for several key neurotoxic proteins, most notably the Amyloid Precursor Protein (APP), alpha-synuclein (SNCA), and the Prion protein (PrP) (Rogers et al., 2002; Friedlich et al., 2007). These elements function as critical post-transcriptional regulators that coordinate protein synthesis with cellular iron availability. In the absence of sufficient iron, Iron Regulatory Proteins (IRP1 and IRP2) bind to the 5'-UTR IRE, creating a steric block that prevents the 43S pre-initiation complex from scanning the mRNA, thus inhibiting translation (Muckenthaler et al., 2017). In neurodegenerative conditions such as Alzheimer's and Parkinson's diseases, iron dyshomeostasis often leads to the pathological upregulation of these proteins. Therapeutic agents like Buntanetap (Posiphen) are designed to target these IRE structures or the IRE-IRP interaction to suppress the translation of neurotoxic species, thereby reducing the accumulation of amyloid plaques and Lewy bodies (Chen-Plotkin et al., 2022). This approach represents a novel strategy for disease modification by intervening at the level of protein production rather than clearance.
Small molecules bind to or stabilize the IRE-IRP complex or otherwise interfere with the 5'-UTR-mediated translation initiation to reduce the synthesis of neurotoxic proteins.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-responsive element in the 5'-untranslated region of neurotoxic protein mRNAs (5'-UTR IRE).